Ampicillin Sodium Injection shortage
To Be Discontinued 5 presentations · 1 manufacturers · first FDA posting 2025-12-08 · last update 2025-12-08
Manufacturers: Sandoz Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Ampicillin Sodium, Injection, 1 g (NDC 0781-9404-95) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of private label only | Posted 12/08/2025 Updated 12/08/2025 Discontinued 12/08/2025 |
| Ampicillin Sodium, Injection, 2 g (NDC 0781-9408-95) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of private label only | Posted 12/08/2025 Updated 12/08/2025 Discontinued 12/08/2025 |
| Ampicillin Sodium, Injection, 10 g (NDC 0781-9409-95) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of private label only | Posted 12/08/2025 Updated 12/08/2025 Discontinued 12/08/2025 |
| Ampicillin Sodium, Injection, 1 g (NDC 0781-9412-92) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of private label only | Posted 12/08/2025 Updated 12/08/2025 Discontinued 12/08/2025 |
| Ampicillin Sodium, Injection, 2 g (NDC 0781-9413-92) | Sandoz Inc. | To Be Discontinued | — | Discontinuation of private label only | Posted 12/08/2025 Updated 12/08/2025 Discontinued 12/08/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)